THE VANADIUM (IV) COMPOUND RESCUES SEPTO-HIPPOCAMPAL CHOLINERGIC NEURONS FROM NEURODEGENERATION IN OLFACTORY BULBECTOMIZED MICEHAN, F; SHIODA, N; MORIGUCHI, S et al.Neuroscience. 2008, Vol 151, Num 3, pp 671-679, issn 0306-4522, 9 p.Article

DECREASED CAMKII AND PKC ACTIVITIES IN SPECIFIC BRAIN REGIONS ARE ASSOCIATED WITH COGNITIVE IMPAIRMENT IN NEONATAL VENTRAL HIPPOCAMPUS-LESIONED RATSYABUKI, Y; NAKAGAWASAI, O; MORIGUCHI, S et al.Neuroscience. 2013, Vol 234, pp 103-115, issn 0306-4522, 13 p.Article

Activation of phosphatidylinositol 3-kinase/protein kinase B pathway by A vanadyl compound mediates its neuroprotective effect in mouse brain ischemiaSHIODA, N; ISHIGAMI, T; HAN, F et al.Neuroscience. 2007, Vol 148, Num 1, pp 221-229, issn 0306-4522, 9 p.Article

PLATELET-ACTIVATING FACTOR-INDUCED SYNAPTIC FACILITATION IS ASSOCIATED WITH INCREASED CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II, PROTEIN KINASE C AND EXTRACELLULAR SIGNAL-REGULATED KINASE ACTIVITIES IN THE RAT HIPPOCAMPAL CA1 REGIONMORIGUCHI, S; SHIODA, N; YAMAMOTO, Y et al.Neuroscience. 2010, Vol 166, Num 4, pp 1158-1166, issn 0306-4522, 9 p.Article

Potentiation of anticoagulant effect of warfarin caused by enantioselective metabolic inhibition by the uricosuric agent benzbromaroneTAKAHASHI, H; SATO, T; SHIMOYAMA, Y et al.Clinical pharmacology and therapeutics. 1999, Vol 66, Num 6, pp 569-581, issn 0009-9236Article

ACCUMULATION OF BETA-AMYLOID IN THE BRAIN MICROVESSELS ACCOMPANIES INCREASED HYPERPHOSPHORYLATED TAU PROTEINS FOLLOWING MICROSPHERE EMBOLISM IN AGED RATSHAN, F; RAIE, A. Ali; SHIODA, N et al.Neuroscience. 2008, Vol 153, Num 2, pp 414-427, issn 0306-4522, 14 p.Article

BIS(1-OXY-2-PYRIDINETHIOLATO)OXOVANADIUM(IV) ENHANCES NEUROGENESIS VIA PHOSPHATIDYLINOSITOL 3-KINASE/Akt AND EXTRACELLULAR SIGNAL REGULATED KINASE ACTIVATION IN THE HIPPOCAMPAL SUBGRANULAR ZONE AFTER MOUSE FOCAL CEREBRAL ISCHEMIASHIODA, N; HAN, F; MORIOKA, M et al.Neuroscience. 2008, Vol 155, Num 3, pp 876-887, issn 0306-4522, 12 p.Article

A mouse TGF-β type I receptor that requires type II receptor for ligand bindingSUZUKI, A; SHIODA, N; MAEDA, T et al.Biochemical and biophysical research communications (Print). 1994, Vol 198, Num 3, pp 1063-1069, issn 0006-291XArticle